These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 34119739)

  • 1. Unraveling neuronal ceroid lipofuscinosis type 2 (CLN2) disease: A tertiary center experience for determinants of diagnostic delay.
    Ardicli D; Haliloglu G; Gocmen R; Gunbey C; Topcu M
    Eur J Paediatr Neurol; 2021 Jul; 33():94-98. PubMed ID: 34119739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photosensitivity is an early marker of neuronal ceroid lipofuscinosis type 2 disease.
    Specchio N; Bellusci M; Pietrafusa N; Trivisano M; de Palma L; Vigevano F
    Epilepsia; 2017 Aug; 58(8):1380-1388. PubMed ID: 28632327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late-onset childhood neuronal ceroid lipofuscinosis: Early clinical and electroencephalographic markers.
    Beltrán L; Valenzuela GR; Loos M; Vargas R; Lizama R; Spinsanti P; Caraballo R
    Epilepsy Res; 2018 Aug; 144():49-52. PubMed ID: 29778029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Electroencephalogram (EEG) and Magnetic Resonance Imaging (MRI) Findings in Early Recognition and Diagnosis of Neuronal Ceroid Lipofuscinosis Type 2 Disease.
    Ho ML; Wirrell EC; Petropoulou K; Sakonju A; Chu D; Seratti G; Palasis S
    J Child Neurol; 2022 Dec; 37(12-14):984-991. PubMed ID: 36184928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expanding the Neuroimaging Phenotype of Neuronal Ceroid Lipofuscinoses.
    Biswas A; Krishnan P; Amirabadi A; Blaser S; Mercimek-Andrews S; Shroff M
    AJNR Am J Neuroradiol; 2020 Oct; 41(10):1930-1936. PubMed ID: 32855186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unique Characteristics of the Photoparoxysmal Response in Patients With Neuronal Ceroid Lipofuscinosis Type 2: Can EEG Be a Biomarker?
    Albert DV; Yin H; De Los Reyes EC; Vidaurre J
    J Child Neurol; 2016 Nov; 31(13):1475-1482. PubMed ID: 27445018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuronal ceroid lipofuscinosis type 2: an Australian case series.
    Johnson AM; Mandelstam S; Andrews I; Boysen K; Yaplito-Lee J; Fietz M; Nagarajan L; Rodriguez-Casero V; Ryan MM; Smith N; Scheffer IE; Ellaway C
    J Paediatr Child Health; 2020 Aug; 56(8):1210-1218. PubMed ID: 32329550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Provoked seizures at the onset of progressive disease contribute to diagnosis delay - A tertiary center experience in a cohort of 22 children with CLN2.
    Kravljanac R; Vucetic Tadic B
    Eur J Paediatr Neurol; 2022 Sep; 40():1-4. PubMed ID: 35792390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI in CLN2 disease patients: Subtle features that support an early diagnosis.
    Aydın K; Havali C; Kartal A; Serdaroğlu A; Haspolat Ş
    Eur J Paediatr Neurol; 2020 Sep; 28():228-236. PubMed ID: 32855042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease characteristics and progression in patients with late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2) disease: an observational cohort study.
    Nickel M; Simonati A; Jacoby D; Lezius S; Kilian D; Van de Graaf B; Pagovich OE; Kosofsky B; Yohay K; Downs M; Slasor P; Ajayi T; Crystal RG; Kohlschütter A; Sondhi D; Schulz A
    Lancet Child Adolesc Health; 2018 Aug; 2(8):582-590. PubMed ID: 30119717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis of neuronal ceroid lipofuscinosis type 2 (CLN2 disease): Expert recommendations for early detection and laboratory diagnosis.
    Fietz M; AlSayed M; Burke D; Cohen-Pfeffer J; Cooper JD; Dvořáková L; Giugliani R; Izzo E; Jahnová H; Lukacs Z; Mole SE; Noher de Halac I; Pearce DA; Poupetova H; Schulz A; Specchio N; Xin W; Miller N
    Mol Genet Metab; 2016 Sep; 119(1-2):160-7. PubMed ID: 27553878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Next-generation sequencing in childhood-onset epilepsies: Diagnostic yield and impact on neuronal ceroid lipofuscinosis type 2 (CLN2) disease diagnosis.
    Gall K; Izzo E; Seppälä EH; Alakurtti K; Koskinen L; Saarinen I; Singh A; Myllykangas S; Koskenvuo J; Alastalo TP
    PLoS One; 2021; 16(9):e0255933. PubMed ID: 34469436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paediatric-onset neuronal ceroid lipofuscinosis: first symptoms and presentation at diagnosis.
    Dozières-Puyravel B; Nasser H; Elmaleh-Bergès M; Lopez Hernandez E; Gelot A; Ilea A; Delanoë C; Puech JP; Caillaud C; Pichard S; Auvin S
    Dev Med Child Neurol; 2020 Apr; 62(4):528-530. PubMed ID: 31489614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerliponase Alfa for the Treatment of Atypical Phenotypes of CLN2 Disease: A Retrospective Case Series.
    Wibbeler E; Wang R; Reyes EL; Specchio N; Gissen P; Guelbert N; Nickel M; Schwering C; Lehwald L; Trivisano M; Lee L; Amato G; Cohen-Pfeffer J; Shediac R; Leal-Pardinas F; Schulz A
    J Child Neurol; 2021 May; 36(6):468-474. PubMed ID: 33356800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of 36 patients from Turkey with neuronal ceroid lipofuscinosis: clinical, neurophysiological, neuroradiological and histopathologic studies.
    Topçu M; Tan H; Yalnizoğlu D; Usubütün A; Saatçi I; Aynaci M; Anlar B; Topaloğlu H; Turanli G; Köse G; Aysun S
    Turk J Pediatr; 2004; 46(1):1-10. PubMed ID: 15074367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profound infantile neuroretinal dysfunction in a heterozygote for the CLN3 genetic defect.
    de los Reyes E; Dyken PR; Phillips P; Brodsky M; Bates S; Glasier C; Mrak RE
    J Child Neurol; 2004 Jan; 19(1):42-6. PubMed ID: 15032383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late infantile neuronal ceroid lipofuscinosis: mutations in the CLN2 gene and clinical course in Spanish patients.
    Pérez-Poyato MS; Marfa MP; Abizanda IF; Rodriguez-Revenga L; Sánchez VC; González MJ; Puñal JE; Pérez AV; González MM; Bermejo AM; Hernández EM; Rosell MJ; Gort L; Milá M
    J Child Neurol; 2013 Apr; 28(4):470-8. PubMed ID: 22832778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical, electrophysiological, imaging, and ultrastructural description in 68 patients with neuronal ceroid lipofuscinoses and its subtypes.
    Jadav RH; Sinha S; Yasha TC; Aravinda H; Gayathri N; Rao S; Bindu PS; Satishchandra P
    Pediatr Neurol; 2014 Jan; 50(1):85-95. PubMed ID: 24120650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late-infantile neuronal ceroid lipofuscinosis (CLN2/Jansky-Bielschowsky type) in Oman.
    Koul R; Al-Futaisi A; Ganesh A; Rangnath Bushnarmuth S
    J Child Neurol; 2007 May; 22(5):555-9. PubMed ID: 17690061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuronal Ceroid Lipofuscinosis: Clinical and Laboratory Profile in Children from Tertiary Care Centre in South India.
    Gowda VK; Vegda H; Sugumar K; Narayanappa G; Srinivasan VM; Santhoshkumar R; Bhat M; Balu S; Naveen MR
    J Pediatr Genet; 2021 Dec; 10(4):266-273. PubMed ID: 34849271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.